Search

Your search keyword '"Doody, Rachelle"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Doody, Rachelle" Remove constraint Author: "Doody, Rachelle" Topic humans Remove constraint Topic: humans
41 results on '"Doody, Rachelle"'

Search Results

1. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

2. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

3. CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP

4. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

5. Progression of brain atrophy in PSP and CBS over 6 months and 1 year

6. Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials.

7. Accelerating rates of cognitive decline and imaging markers associated with &bgr;-amyloid pathology

8. Assessment of the genetic variance of late-onset Alzheimer's disease

9. Better verbal memory in women than men in MCI despite similar levels of hippocampal atrophy

10. Periventricular hyperintensities are associated with elevated cerebral amyloid

11. Memory, executive, and multidomain subtle cognitive impairment

12. Brain structure and function as mediators of the effects of amyloid on memory

13. Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

14. Mild cognitive impairment with suspected nonamyloid pathology (SNAP)

15. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

16. Vascular burden and Alzheimer disease pathologic progression

17. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.

18. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium.

19. Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial

20. A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease

21. Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment

22. Trial of Prasinezumab in Early-Stage Parkinson's Disease

23. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease

24. Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration

25. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease

26. The genetic architecture of the human cerebral cortex

27. Severity dependent distribution of impairments in PSP and CBS: Interactive Visualizations

28. In vivo staging of regional amyloid deposition

29. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load

30. A Hidden Markov Model approach to analyze longitudinal ternary outcomes when some observed states are possibly misclassified

31. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease?

32. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease

33. Identification of common variants associated with human hippocampal and intracranial volumes

34. Common genetic variants influence human subcortical brain structures

35. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

36. Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes

37. Applying automated MR-based diagnostic methods to the memory clinic: A prospective study

38. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects

39. Exploring Self-neglect in Older Adults: Preliminary Findings of the Self-Neglect Severity Scale and Next Steps

40. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

41. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease

Catalog

Books, media, physical & digital resources